{"DataElement":{"publicId":"3448032","version":"1","preferredName":"Vulvar Cancer American Joint Committee on Cancer (AJCC) Edition 7 Group Stage","preferredDefinition":"Stage group determined from information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for carcinoma of the vulva.","longName":"3447916v1.0:3448005v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"3447916","version":"1","preferredName":"Vulvar Cancer Stage Grouping","preferredDefinition":"The external, visible part of the female genitalia surrounding the urethral and vaginal opening. The vulva includes the clitoris and inner as well as outer labia._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.","longName":"3447902v1.0:2230143v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3447902","version":"1","preferredName":"Vulva Neoplasm","preferredDefinition":"The external, visible part of the female genitalia surrounding the urethral and vaginal opening. The vulva includes the clitoris and inner as well as outer labia.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","longName":"C12408:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vulva","conceptCode":"C12408","definition":"The external, visible part of the female genitalia surrounding the urethral and vaginal opening. The vulva includes the clitoris and inner as well as outer labia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF153D01-E461-1731-E040-BB89AD437FEE","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"ONEDATA","dateModified":"2012-05-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2230143","version":"1","preferredName":"Stage Grouping","preferredDefinition":"Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F752037A-4CC2-36A8-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-05-18","modifiedBy":"ONEDATA","dateModified":"2005-05-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF153D01-E547-1731-E040-BB89AD437FEE","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3448005","version":"1","preferredName":"Vulvar Cancer American Joint Committee on Cancer (AJCC) Edition 7 Group Stage","preferredDefinition":"A term that refers to the staging of vulvar carcinoma according to the American Joint Committee on Cancer, 7th edition._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3448005v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"13","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Stage unknown","valueDescription":"Stage Unknown","ValueMeaning":{"publicId":"3357508","version":"1","preferredName":"Stage Unknown","longName":"3357508","preferredDefinition":"A finding indicating that the extent of organ/tissue involvement by a malignant neoplasm is not reported or not assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage Unknown","conceptCode":"C92207","definition":"The extent of organ/tissue involvement by a malignant neoplasm is not reported or not assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D76279-6263-2CA8-E040-BB89AD434A54","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BF228FC9-272F-E31F-E040-BB89AD4319C7","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"ONEDATA","dateModified":"2012-05-03","deletedIndicator":"No"},{"value":"0","valueDescription":"Stage 0 Vulvar Cancer","ValueMeaning":{"publicId":"3448007","version":"1","preferredName":"Stage 0 Vulvar Cancer","longName":"3448007","preferredDefinition":"Stage 0 includes: Tis, N0, M0.  Tis: Carcinoma in situ (preinvasive carcinoma). N0: No regional lymph node metastasis.  M0: No distant metastasis. FIGO no longer includes stage 0. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage 0 Vulvar Cancer AJCC v7","conceptCode":"C89445","definition":"Stage 0 includes: Tis, N0, M0.  Tis: Carcinoma in situ (preinvasive carcinoma). N0: No regional lymph node metastasis.  M0: No distant metastasis. FIGO no longer includes stage 0. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF228FC9-273C-E31F-E040-BB89AD4319C7","latestVersionIndicator":"Yes","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BF228FC9-2755-E31F-E040-BB89AD4319C7","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"ONEDATA","dateModified":"2012-05-03","deletedIndicator":"No"},{"value":"I","valueDescription":"Stage I Vulvar Cancer","ValueMeaning":{"publicId":"3448009","version":"1","preferredName":"Stage I Vulvar Cancer","longName":"3448009","preferredDefinition":"Stage I includes: T1, N0, M0. T1: Invasive vulvar cancer confined to the vulva or perineum. N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage I Vulvar Cancer AJCC v7","conceptCode":"C89447","definition":"Stage I includes: T1, N0, M0. T1: Invasive vulvar cancer confined to the vulva or perineum. N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF228FC9-2762-E31F-E040-BB89AD4319C7","latestVersionIndicator":"Yes","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BF228FC9-277B-E31F-E040-BB89AD4319C7","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"ONEDATA","dateModified":"2012-05-03","deletedIndicator":"No"},{"value":"IA","valueDescription":"Stage IA Vulvar Cancer","ValueMeaning":{"publicId":"3448011","version":"1","preferredName":"Stage IA Vulvar Cancer","longName":"3448011","preferredDefinition":"Stage IA includes: T1a, N0, M0. T1a: Tumor confined to the vulva and perineum, 2 cm or less in greatest dimension, and with stromal invasion no greater than 1 mm.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IA Vulvar Cancer AJCC v7","conceptCode":"C89448","definition":"Stage IA includes: T1a, N0, M0. T1a: Tumor confined to the vulva and perineum, 2 cm or less in greatest dimension, and with stromal invasion no greater than 1 mm.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF228FC9-2788-E31F-E040-BB89AD4319C7","latestVersionIndicator":"Yes","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BF228FC9-27A1-E31F-E040-BB89AD4319C7","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"ONEDATA","dateModified":"2012-05-03","deletedIndicator":"No"},{"value":"IB","valueDescription":"Stage IB Vulvar Cancer","ValueMeaning":{"publicId":"3448013","version":"1","preferredName":"Stage IB Vulvar Cancer","longName":"3448013","preferredDefinition":"Stage IB includes: T1b, N0, M0.  T1b: Vulvar cancer with tumor size greater than 2 cm, or any size with stromal invasion more than 1.0 mm, confined to the vulva or perineum.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB Vulvar Cancer AJCC v7","conceptCode":"C89449","definition":"Stage IB includes: T1b, N0, M0.  T1b: Vulvar cancer with tumor size greater than 2 cm, or any size with stromal invasion more than 1.0 mm, confined to the vulva or perineum.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF228FC9-27AE-E31F-E040-BB89AD4319C7","latestVersionIndicator":"Yes","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BF228FC9-27C7-E31F-E040-BB89AD4319C7","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"ONEDATA","dateModified":"2012-05-03","deletedIndicator":"No"},{"value":"II","valueDescription":"Stage II Vulvar Cancer","ValueMeaning":{"publicId":"3448015","version":"1","preferredName":"Stage II Vulvar Cancer","longName":"3448015","preferredDefinition":"Stage II includes: T2, N0, M0.  T2: Vulvar cancer with tumor of any size with extension to adjacent perineal structures (lower/distal 1/3 urethra, lower/distal 1/3 vagina, anal involvement).  N0: No regional lymph node metastasis.  M0: No distant metastasis.  (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage II Vulvar Cancer AJCC v7","conceptCode":"C89451","definition":"Stage II includes: T2, N0, M0.  T2: Vulvar cancer with tumor of any size with extension to adjacent perineal structures (lower/distal 1/3 urethra, lower/distal 1/3 vagina, anal involvement).  N0: No regional lymph node metastasis.  M0: No distant metastasis.  (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF228FC9-27D4-E31F-E040-BB89AD4319C7","latestVersionIndicator":"Yes","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BF228FC9-27ED-E31F-E040-BB89AD4319C7","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"ONEDATA","dateModified":"2012-05-03","deletedIndicator":"No"},{"value":"IIIA","valueDescription":"Stage IIIA Vulvar Cancer","ValueMeaning":{"publicId":"3448017","version":"1","preferredName":"Stage IIIA Vulvar Cancer","longName":"3448017","preferredDefinition":"Stage IIIA includes: (T1/T2, N1a/N1b, M0); T1: Invasive vulvar cancer confined to the vulva or perineum.  T2: Vulvar cancer with tumor of any size with extension to adjacent perineal structures (lower/distal 1/3 urethra, lower/distal 1/3 vagina, anal involvement).  N1a: Vulvar cancer with one or two lymph node metastasis each measuring 5 mm or less.  N1b: Vulvar cancer with one lymph node metastasis measuring 5 mm or greater.  M0: No distant metastasis.  (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIA Vulvar Cancer AJCC v7","conceptCode":"C87003","definition":"Stage IIIA includes: (T1/T2, N1a/N1b, M0); T1: Invasive vulvar cancer confined to the vulva or perineum.  T2: Vulvar cancer with tumor of any size with extension to adjacent perineal structures (lower/distal 1/3 urethra, lower/distal 1/3 vagina, anal involvement).  N1a: Vulvar cancer with one or two lymph node metastasis each measuring 5 mm or less.  N1b: Vulvar cancer with one lymph node metastasis measuring 5 mm or greater.  M0: No distant metastasis.  (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF228FC9-27FA-E31F-E040-BB89AD4319C7","latestVersionIndicator":"Yes","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BF228FC9-2813-E31F-E040-BB89AD4319C7","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"ONEDATA","dateModified":"2012-05-03","deletedIndicator":"No"},{"value":"IIIB","valueDescription":"Stage IIIB Vulvar Cancer","ValueMeaning":{"publicId":"3448019","version":"1","preferredName":"Stage IIIB Vulvar Cancer","longName":"3448019","preferredDefinition":"Stage IIIB includes: (T1/T2, N2a/N2b, M0).  T1: Invasive vulvar cancer confined to the vulva or perineum.  T2: Vulvar cancer with tumor of any size with extension to adjacent perineal structures (lower/distal 1/3 urethra, lower/distal 1/3 vagina, anal involvement).  N2a: Vulvar cancer with three or more lymph node metastases each measuring 5 mm or less.  N2b: Vulvar cancer with two or more lymph node metastases measuring 5 mm or greater.  M0: No distant metastasis.  (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIB Vulvar Cancer AJCC v7","conceptCode":"C87004","definition":"Stage IIIB includes: (T1/T2, N2a/N2b, M0).  T1: Invasive vulvar cancer confined to the vulva or perineum.  T2: Vulvar cancer with tumor of any size with extension to adjacent perineal structures (lower/distal 1/3 urethra, lower/distal 1/3 vagina, anal involvement).  N2a: Vulvar cancer with three or more lymph node metastases each measuring 5 mm or less.  N2b: Vulvar cancer with two or more lymph node metastases measuring 5 mm or greater.  M0: No distant metastasis.  (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF228FC9-2820-E31F-E040-BB89AD4319C7","latestVersionIndicator":"Yes","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BF228FC9-2839-E31F-E040-BB89AD4319C7","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"ONEDATA","dateModified":"2012-05-03","deletedIndicator":"No"},{"value":"IIIC","valueDescription":"Stage IIIC Vulvar Cancer","ValueMeaning":{"publicId":"3448021","version":"1","preferredName":"Stage IIIC Vulvar Cancer","longName":"3448021","preferredDefinition":"Stage IIIC includes: (T1/T2, N2c, M0).  T1: Invasive vulvar cancer confined to the vulva or perineum.  T2: Vulvar cancer with tumor of any size with extension to adjacent perineal structures (lower/distal 1/3 urethra, lower/distal 1/3 vagina, anal involvement).  N2c: Vulvar cancer with lymph node metastasis with extracapsular spread.  M0: No distant metastasis.  (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIC Vulvar Cancer AJCC v7","conceptCode":"C87005","definition":"Stage IIIC includes: (T1/T2, N2c, M0).  T1: Invasive vulvar cancer confined to the vulva or perineum.  T2: Vulvar cancer with tumor of any size with extension to adjacent perineal structures (lower/distal 1/3 urethra, lower/distal 1/3 vagina, anal involvement).  N2c: Vulvar cancer with lymph node metastasis with extracapsular spread.  M0: No distant metastasis.  (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF228FC9-2846-E31F-E040-BB89AD4319C7","latestVersionIndicator":"Yes","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BF228FC9-285F-E31F-E040-BB89AD4319C7","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"ONEDATA","dateModified":"2012-05-03","deletedIndicator":"No"},{"value":"IVA","valueDescription":"Stage IVA Vulvar Cancer","ValueMeaning":{"publicId":"3448023","version":"1","preferredName":"Stage IVA Vulvar Cancer","longName":"3448023","preferredDefinition":"Stage IVA includes: (T1/T2, N3, M0); (T3, Any N, M0).  T1: Invasive vulvar cancer confined to the vulva or perineum.  T2: Vulvar cancer with tumor of any size with extension to adjacent perineal structures (lower/distal 1/3 urethra, lower/distal 1/3 vagina, anal involvement).  T3: Vulvar cancer with tumor of any size with extension to any of the following: upper/proximal 2/3 urethra, upper/proximal 2/3 vagina, bladder mucosa, rectal mucosa, or fixed to pelvic bone.  N3: Vulvar cancer with fixed or ulcerated regional lymph node metastasis.  M0: No distant metastasis.  (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IVA Vulvar Cancer AJCC v7","conceptCode":"C89454","definition":"Stage IVA includes: (T1/T2, N3, M0); (T3, Any N, M0).  T1: Invasive vulvar cancer confined to the vulva or perineum.  T2: Vulvar cancer with tumor of any size with extension to adjacent perineal structures (lower/distal 1/3 urethra, lower/distal 1/3 vagina, anal involvement).  T3: Vulvar cancer with tumor of any size with extension to any of the following: upper/proximal 2/3 urethra, upper/proximal 2/3 vagina, bladder mucosa, rectal mucosa, or fixed to pelvic bone.  N3: Vulvar cancer with fixed or ulcerated regional lymph node metastasis.  M0: No distant metastasis.  (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF228FC9-286C-E31F-E040-BB89AD4319C7","latestVersionIndicator":"Yes","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BF228FC9-2885-E31F-E040-BB89AD4319C7","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"ONEDATA","dateModified":"2012-05-03","deletedIndicator":"No"},{"value":"IVB","valueDescription":"Stage IVB Vulvar Cancer","ValueMeaning":{"publicId":"3448025","version":"1","preferredName":"Stage IVB Vulvar Cancer","longName":"3448025","preferredDefinition":"Stage IVB includes: Any T, Any N, M1.  M1: distant metastasis (including pelvic lymph node metastasis).  (AJCC 6th and 7th eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IVB Vulvar Cancer AJCC v6 and v7","conceptCode":"C27247","definition":"Stage IVB includes: Any T, Any N, M1.  M1: distant metastasis (including pelvic lymph node metastasis).  (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF228FC9-2892-E31F-E040-BB89AD4319C7","latestVersionIndicator":"Yes","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BF228FC9-28AB-E31F-E040-BB89AD4319C7","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"ONEDATA","dateModified":"2012-05-03","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3448004","version":"1","preferredName":"Vulvar Carcinoma by AJCC v7 Stage Stage Grouping Stage","preferredDefinition":"No Value Exists:An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C91203:C38027:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vulvar Cancer by AJCC v7 Stage","conceptCode":"C91203","definition":"A term that refers to the staging of vulvar carcinoma according to the American Joint Committee on Cancer, 7th edition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF228FC9-2706-E31F-E040-BB89AD4319C7","latestVersionIndicator":"Yes","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"ONEDATA","dateModified":"2012-05-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF228FC9-2717-E31F-E040-BB89AD4319C7","latestVersionIndicator":"Yes","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"COOPERM","dateModified":"2012-05-07","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"3447900","version":"1","longName":"Vulva","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"5777533","version":"1","longName":"Vulvar","context":"NCI Standards"}]}],"AlternateNames":[{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"}],"ReferenceDocuments":[{"name":"Disease Stage","type":"Preferred Question Text","description":"Disease Stage","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"BF228FC9-29FC-E31F-E040-BB89AD4319C7","latestVersionIndicator":"Yes","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}